Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 318   Home Print this page  Email this page Small font size Default font size Increase font size


 
Table of Contents
LETTER TO EDITOR
Year : 2015  |  Volume : 7  |  Issue : 1  |  Page : 127-128  

A case of recurrent retroperitoneal lymphangioleiomyomatosis treated with progesterone therapy


1 Department of Internal Medicine, Trinitas Regional Medical Center, Elizabeth, USA
2 Department of Hematology and Oncology, Saint Michael's Medical Center, Newark, New Jersey, USA
3 Department of Medical Oncology, Trinitas Regional Medical Center, Elizabeth, USA

Date of Web Publication6-Jan-2015

Correspondence Address:
Hamid Shaaban
Department of Hematology and Oncology, Saint Michael's Medical Center, Newark, New Jersey
USA
Login to access the Email id


DOI: 10.4103/0974-7796.148664

PMID: 25657565

Rights and Permissions

How to cite this article:
Basnet A, Shaaban H, Kessler W. A case of recurrent retroperitoneal lymphangioleiomyomatosis treated with progesterone therapy. Urol Ann 2015;7:127-8

How to cite this URL:
Basnet A, Shaaban H, Kessler W. A case of recurrent retroperitoneal lymphangioleiomyomatosis treated with progesterone therapy. Urol Ann [serial online] 2015 [cited 2020 Jan 29];7:127-8. Available from: http://www.urologyannals.com/text.asp?2015/7/1/127/148664

Sir,

Lymphangioleiomyomatosis (LAM) is a rare, progressive disease of unknown etiology that generally affects women of childbearing age. It is characterized by the abnormal proliferation of smooth muscle cells causing gradual obstruction of small airways, resulting in the formation of thin-walled pulmonary cysts, leading to respiratory failure and death. [1] LAM is predominantly a lung disorder; however, extrapulmonary involvement, such as renal angiomyolipomas (which occurs in the presence of tuberous sclerosis [TSC]) and retroperitoneal masses, can occur in up to 75% of cases. No therapy is of proven benefit in LAM. Some studies support hormonal manipulation. [2] We report here a case of recurrent retroperitoneal LAM in a patient without any pulmonary involvement, who clinically responded with resolution of symptoms and objective ultrasound findings within a month, after receiving progesterone therapy.

A 24-year-old female patient presented to the emergency room with acute severe left sided abdominal pain. Physical examination and laboratories studies were unremarkable. A noncontrast computed tomography (CT) of the chest, abdomen and pelvis revealed multiple retroperitoneal, mesenteric, and pelvic sidewall hypodense masses with a sub-carinal mass of 3.2 × 3.5 cm with no lung parenchymal involvement [Figure 1]. Ultrasound of the abdomen [Figure 2]a revealed para-aortic and mesenteric masses with decreased echogenicity. The initial impression was retroperitoneal lymphadenopathy. A laparoscopic excisional biopsy of the mesenteric mass showed histologic findings consistent with LAM. Her histopathology [Figure 3]a and b revealed a network of lymphatic spaces lined by a single layer of endothelium, surrounded by fascicles and bundles of smooth muscle cells and occasional lymphoid follicles and congested vascular spaces are noted among the smooth muscle bundles. The patient received two doses of intramuscular (IM) medroxy-progesterone (Depo-Provera) 150 mg at 3 months interval. A 6 months follow-up ultrasound showed resolution of masses. However, the patient was lost follow-up for 2 years until the time she presented again with acute abdominal pain and retroperitoneal masses on ultrasound scan [Figure 2]a. She was given the Depo-Provera 150 mg IM. The patient clinically and radiologically responded within a week [Figure 2]b.
Figure 1: Computed tomography scans revealing evidence of retroperitoneal masses

Click here to view
Figure 2: (a) Ultrasound revealing evidence of hypoechoic para-aortic masses (b) Ultrasound repeated after 1 week revealed resolution with decrease in size of the para-aortic hypoechoic masses

Click here to view
Figure 3: (a) Histopathology (H and E staining) revealed smooth muscle cells that are plump and possess pale to clear cytoplasm. There is also evidence of interspersed vascular spaces (b) Histopathology (HMB-45 staining) revealing granular cytoplasm consistent with retroperitoneal lymphangioleiomyomatosis

Click here to view


Lymphangioleiomyomatosis, is a rare, idiopathic disorder involving the lungs, axial lymphatics in the thorax and rarely abdomen. [1],[2] Extrapulmonary LAM as the initial presentation of the disease is highly unusual. Extra pulmonary LAM is usually associated with renal angiomyolipomas (54% of cases), enlarged abdominal lymph nodes (39%), and lymphangiomyoma (16%). Less commonly, ascites (10%) and hepatic angiomyolipoma (4%) may be present. [3],[4] The clinical presentation of retroperitoneal LAM can vary from abdominal pain to shock due to bleeding from renal angiomyolipomas. LAM can occur without other disease ("sporadic" LAM) or in association with TSC. [1-4] Histopathology with immunohistochemical study of tissue is crucial in the diagnosis of this rare disease entity. Sonographic features and CT scan findings can be difficult to differentiate from malignancy. Supportive data for treatment of LAM is limited. Most therapies such as progestational, antiestrogen agents, rapamycin, and sirolimus provide improvement or stabilization of disease. [5] Our case illustrates a patient with recurrent extrapulmonary LAM that had a resolution of symptoms and ultrasound findings after progesterone treatment.

 
   References Top

1.
Sullivan EJ. Lymphangioleiomyomatosis: A review. Chest 1998;114:1689-703.  Back to cited text no. 1
    
2.
Kelly J, Moss J. Lymphangioleiomyomatosis. Am J Med Sci 2001;321:17-25.  Back to cited text no. 2
    
3.
Derweduwen AM, Verbeken E, Stas M, Verschakelen J, Coolen J, Verleden G, et al. Extrapulmonary lymphangioleiomyomatosis: A wolf in sheep′s clothing. Thorax 2013;68:111-3.  Back to cited text no. 3
    
4.
Gopinath D, Attarbashi S, Reid F, Seif M. Extrapulmonary lymphangioleiomyomatosis complicated by vesicovaginal fistula. J Obstet Gynaecol 2013;33:910-2.  Back to cited text no. 4
    
5.
Matsui K, Tatsuguchi A, Valencia J, Yu ZX, Bechtle J, Beasley MB, et al. Extrapulmonary lymphangioleiomyomatosis (LAM): Clinicopathologic features in 22 cases. Hum Pathol 2000;31:1242-8.  Back to cited text no. 5
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References
    Article Figures

 Article Access Statistics
    Viewed1330    
    Printed35    
    Emailed0    
    PDF Downloaded150    
    Comments [Add]    

Recommend this journal